Literature DB >> 9168922

Two N-terminal self-association domains are required for the dominant negative transcriptional activity of WT1 Denys-Drash mutant proteins.

G Holmes1, S Boterashvili, M English, B Wainwright, J Licht, M Little.   

Abstract

Patients with Denys-Drash syndrome (DDS) have been shown to be constitutionally heterozygous for mutations of the WT1 gene. Almost all DDS mutations inactivate or remove the DNA-binding zinc finger region of WT1 and the resulting mutant proteins appear to act in a dominant negative manner. This may occur via WT1 self-association, which has been shown to involve the first 180 amino acids. By creating a series of N-terminal deletions, we have further investigated WT1 self-association using a yeast di-hybrid system and an in vitro protein binding assay. Our results suggest that there are two distinct domains within the N-terminal region facilitating self-association, residing from amino acids 1-45 and 157-253. Co-transfection of WT1 with progressively shorter N-terminal constructs demonstrates that both of these sites are required for a dominant negative activity as assessed by activation of a reporter construct.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9168922     DOI: 10.1006/bbrc.1997.6545

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Wnt signaling in kidney development and disease.

Authors:  Kaisa Pulkkinen; Subramanian Murugan; Seppo Vainio
Journal:  Organogenesis       Date:  2008-04       Impact factor: 2.500

2.  Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance.

Authors:  Lihua Dong; Stefan Pietsch; Zenglai Tan; Birgit Perner; Ralph Sierig; Dagmar Kruspe; Marco Groth; Ralph Witzgall; Hermann-Josef Gröne; Matthias Platzer; Christoph Englert
Journal:  J Am Soc Nephrol       Date:  2015-01-02       Impact factor: 10.121

Review 3.  A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome.

Authors:  Suzanne Little; Sandra Hanks; Linda King-Underwood; Sue Picton; Catherine Cullinane; Elizabeth Rapley; Nazneen Rahman; Kathy Pritchard-Jones
Journal:  Pediatr Nephrol       Date:  2004-10-21       Impact factor: 3.714

Review 4.  Regulation of gene expression by WT1 in development and tumorigenesis.

Authors:  Leif W Ellisen
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

5.  Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396).

Authors:  Charles E Patek; David G Brownstein; Stewart Fleming; Caroline Wroe; Lorraine Rose; Anna Webb; Rachel L Berry; Paul S Devenney; Marion Walker; Oliver D K Maddocks; Nicola J Lawrence; David J Harrison; Katrina M Wood; Colin G Miles; Martin L Hooper
Journal:  Transgenic Res       Date:  2007-11-27       Impact factor: 2.788

Review 6.  Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1).

Authors:  Eneda Toska; Stefan G E Roberts
Journal:  Biochem J       Date:  2014-07-01       Impact factor: 3.857

7.  Refining transcriptional programs in kidney development by integration of deep RNA-sequencing and array-based spatial profiling.

Authors:  Rathi D Thiagarajan; Nicole Cloonan; Brooke B Gardiner; Tim R Mercer; Gabriel Kolle; Ehsan Nourbakhsh; Shivangi Wani; Dave Tang; Keerthana Krishnan; Kylie M Georgas; Bree A Rumballe; Han S Chiu; Jason A Steen; John S Mattick; Melissa H Little; Sean M Grimmond
Journal:  BMC Genomics       Date:  2011-09-05       Impact factor: 3.969

8.  Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modifications.

Authors:  Hideharu Hashimoto; Xing Zhang; Yu Zheng; Geoffrey G Wilson; Xiaodong Cheng
Journal:  Nucleic Acids Res       Date:  2016-09-04       Impact factor: 16.971

9.  Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.

Authors:  Dongxue Wang; John R Horton; Yu Zheng; Robert M Blumenthal; Xing Zhang; Xiaodong Cheng
Journal:  Nucleic Acids Res       Date:  2018-05-04       Impact factor: 16.971

10.  The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.

Authors:  Youqi Han; Serban San-Marina; Lin Yang; Haytham Khoury; Mark D Minden
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.